Lack of diverse data for GLP-1s in Asia

Posted by casey613 in Safety & Side Effects - 2 points, 1 comments.

https://scitechdaily.com/glp-1-drugs-like-ozempic-work-but-new-research-reveals-a-major-catch

This article talks about how most GLP-1 weight loss studies barely include people from Southeast Asia. It basically says the data we have might not apply to everyone because body composition and eating habits vary so much across different regions.

I find it a bit worrying that the main research is so skewed toward Western populations. For me, it feels like we are just guessing if the side effect profiles are the same here in Singapore. I have seen people struggle with different gastric reactions than what the US brochures mention, so the lack of local data is a real gap. It makes me wonder if the standard dosing ranges are actually optimal for us or if we are just following a template that does not fit.

Do you think the lean mass loss associated with these compounds happens faster or slower depending on your ethnic background? I would be curious if anyone here has tracked their muscle mass specifically while on a GLP-1.

Comments

• sleep_coastal: I’ve followed a few GLP‑1 trials here in the Midwest and then watched what patients overseas report. Anecdotally, the early weight loss looks similar, but the rate of lean‑mass loss can differ. 3 kg of lean‑mass drop, pretty mild. In Singapore, I hear people get more bloating and early satiety, which can make them cut back on protein. I’d love compelled to hear if anyone’s got serial muscle‑mass data while on a GLP‑1 in Asia. That’d help us see if the standard dosing truly suits everyone.

Community discussion - research and educational context only. Not medical advice.